These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22179832)

  • 1. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
    Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL
    Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.
    Dart DA; Spencer-Dene B; Gamble SC; Waxman J; Bevan CL
    Endocr Relat Cancer; 2009 Dec; 16(4):1157-69. PubMed ID: 19635783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.
    Gamble SC; Chotai D; Odontiadis M; Dart DA; Brooke GN; Powell SM; Reebye V; Varela-Carver A; Kawano Y; Waxman J; Bevan CL
    Oncogene; 2007 Mar; 26(12):1757-68. PubMed ID: 16964284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
    Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
    Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
    Fletcher CE; Dart DA; Sita-Lumsden A; Cheng H; Rennie PS; Bevan CL
    Hum Mol Genet; 2012 Jul; 21(14):3112-27. PubMed ID: 22505583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.
    Jia L; Shen HC; Wantroba M; Khalid O; Liang G; Wang Q; Gentzschein E; Pinski JK; Stanczyk FZ; Jones PA; Coetzee GA
    Mol Cell Biol; 2006 Oct; 26(19):7331-41. PubMed ID: 16980632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells.
    Koushyar S; Uysal-Onganer P; Jiang WG; Dart DA
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.
    Kumagai J; Hofland J; Erkens-Schulze S; Dits NF; Steenbergen J; Jenster G; Homma Y; de Jong FH; van Weerden WM
    Prostate; 2013 Nov; 73(15):1636-50. PubMed ID: 23996639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
    Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
    BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING3 promotes prostate cancer growth by activating the androgen receptor.
    Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
    BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
    Weber H; Ruoff R; Garabedian MJ
    PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase.
    Jathal MK; Siddiqui S; Vasilatis DM; Durbin Johnson BP; Drake C; Mooso BA; D'Abronzo LS; Batra N; Mudryj M; Ghosh PM
    J Biol Chem; 2023 Aug; 299(8):104973. PubMed ID: 37380074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
    Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.